Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Social phobia: an update

C S Fones1, G G Manfro, M H Pollack

  • 1Anxiety Disorders Program, Massachusetts General Hospital, Boston 02114, USA.

Harvard Review of Psychiatry
|March 11, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Impulsivity-based thrifty eating phenotype and the protective role of n-3 PUFAs intake in adolescents.

Translational psychiatry·2016
Same author

Early life trauma is associated with decreased peripheral levels of thyroid-hormone T3 in adolescents.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2015
Same author

Anxiety in childhood across the globe: findings from meta-regression analyses of the past 15 years (1998-2013).

European child & adolescent psychiatry·2015
Same author

Brain connectomics predict response to treatment in social anxiety disorder.

Molecular psychiatry·2015
Same author

Attention network functioning in children with anxiety disorders, attention-deficit/hyperactivity disorder and non-clinical anxiety.

Psychological medicine·2015
Same journal

A Student-Faculty Collaboration: Embedding Trauma-Informed Care in Medical Education.

Harvard review of psychiatry·2026
Same journal

Inpatient Management of Benzodiazepine Withdrawal: A Narrative Review of a Systematic, Individualized Taper Design.

Harvard review of psychiatry·2026
Same journal

Application of mHealth Approaches to Increase Access to and Engagement of Mental Health Treatment Among Underserved Communities.

Harvard review of psychiatry·2026
Same journal

Integrating Climate Change and Mental Health into Medical Education: A Narrative Review of Interventions and Assessment Tools.

Harvard review of psychiatry·2026
Same journal

The Long Road Back: An Integrative and Interdisciplinary Approach to Care After Traumatic Brain Injury.

Harvard review of psychiatry·2026
Same journal

Poverty, Policy, and Mental Health Inequities: Evidence, Challenges, and Opportunities.

Harvard review of psychiatry·2026
See all related articles

Social phobia, a common anxiety disorder, has evolved diagnostically and presents challenges in recognition and cross-cultural understanding. Effective treatments include medications and cognitive-behavioral therapy.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Epidemiology

Background:

  • Social phobia, now in its DSM-IV form, has a complex diagnostic history.
  • Understanding social phobia requires considering its differential diagnoses, cross-cultural variations, and prevalence.
  • Underrecognition and high comorbidity with other disorders are significant concerns.

Purpose of the Study:

  • To review the current literature on social phobia.
  • To discuss diagnostic evolution, epidemiology, etiology, and treatment options.

Main Methods:

  • Literature review of social phobia.
  • Analysis of diagnostic criteria evolution (DSM-IV).
  • Examination of epidemiological, etiological, and treatment research.

Related Experiment Videos

Main Results:

  • Social phobia has a lifetime prevalence of 13.3% in the US.
  • Common comorbidities include anxiety disorders, depression, alcohol abuse, and personality disorders.
  • Both pharmacotherapy (MAOIs, SSRIs, benzodiazepines, beta-blockers) and cognitive-behavioral therapy are effective treatments.

Conclusions:

  • Social phobia is a prevalent disorder with diagnostic complexities and frequent comorbidities.
  • Etiology is understood through psychodynamic, genetic, neurobiological, and neuroimaging research.
  • Evidence-based treatments include pharmacotherapy and cognitive-behavioral interventions.